HIV/AIDS: Preventive Medicine
The question
To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what steps he plans to take to support the scale up of the provision of long-acting HIV prevention medicines now entering the market.
Answered by Stephen Doughty
The UK remains committed to sustainable development goal 3.3 in ending HIV as a public health threat by 2030. Long-acting technologies have the potential to be game-changers in the global response to HIV, but only if they reach the countries and communities that need them most. The UK supports key partners to improve access to long-acting technologies, including Unitaid who recently committed £17 million in market-shaping grants with the Wits Institute in South Africa and Fiotec in Brazil to accelerate affordable access to Lenacapavir.
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →